A Second Study of NicVAX/Placebo as an Aid for Smoking Cessation

Clinical trial NCT01102114 · COMPLETED

Trial details

NCT number: NCT01102114
Sponsor: Nabi Biopharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Smoking Cessation

Start date: 2010-03-01
Primary completion: 2011-11-01
Enrollment: 1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.